HELX
HELX
About Franklin Genomic Advancements ETF
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of...
About Franklin Genomic Advancements ETF
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 NTRA | Natera, Inc. | 6.57% | 7.13K | $1.49M |
 GH | Guardant Health, Inc. | 6.28% | 15.72K | $1.42M |
 KRYS | Krystal Biotech, Inc. | 5.36% | 4.42K | $1.21M |
 UTHR | United Therapeutics Corporation | 4.37% | 1.68K | $988.48K |
 BBIO | BridgeBio Pharma, Inc. | 4.14% | 12.19K | $935.74K |
 LGND | Ligand Pharmaceuticals Incorporated | 3.89% | 3.79K | $879.52K |
 INSM | Insmed Incorporated | 3.79% | 5.93K | $857.05K |
 ADPT | Adaptive Biotechnologies Corporation | 3.09% | 48.24K | $698.11K |
 MEDP | Medpace Holdings, Inc. | 3.06% | 1.33K | $690.84K |
 VRTX | Vertex Pharmaceuticals Incorporated | 2.80% | 1.44K | $633.12K |
 REGN | Regeneron Pharmaceuticals, Inc. | 2.48% | 748 | $561.43K |
 CTVA | Corteva, Inc. | 2.45% | 6.90K | $554.67K |
 LLY | Eli Lilly and Company | 2.43% | 593 | $549.73K |
 ALNY | Alnylam Pharmaceuticals, Inc. | 2.31% | 1.69K | $522.40K |
 TEM | Tempus AI, Inc. | 2.16% | 8.73K | $487.52K |
 IONS | Ionis Pharmaceuticals, Inc. | 2.00% | 5.96K | $451.00K |
 BNTX | BioNTech SE | 1.98% | 4.34K | $446.67K |
 TWST | Twist Bioscience Corporation | 1.90% | 7.18K | $429.68K |
 TVTX | Travere Therapeutics, Inc. | 1.83% | 10.13K | $412.96K |
 STOK | Stoke Therapeutics, Inc. | 1.74% | 10.54K | $392.79K |
SECTOR HOLDINGS
Healthcare
Cash & Others
Basic Materials
TechnologyASSET ALLOCATION BY REGION
United States
South Korea
United Kingdom
Germany
Netherlands
Switzerland
Ireland
SingaporeSECTOR HOLDINGS
Healthcare Cash & Others Basic Materials TechnologyASSET ALLOCATION BY REGION
United States South Korea United Kingdom Germany Netherlands Switzerland Ireland SingaporeHoldings (Top 20)
NTRA
Natera, Inc.
GH
Guardant Health, Inc.
KRYS
Krystal Biotech, Inc.
UTHR
United Therapeutics Corporation
BBIO
BridgeBio Pharma, Inc.
LGND
Ligand Pharmaceuticals Incorporated
INSM
Insmed Incorporated
ADPT
Adaptive Biotechnologies Corporation
MEDP
Medpace Holdings, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
CTVA
Corteva, Inc.
LLY
Eli Lilly and Company
ALNY
Alnylam Pharmaceuticals, Inc.
TEM
Tempus AI, Inc.
IONS
Ionis Pharmaceuticals, Inc.
BNTX
BioNTech SE
TWST
Twist Bioscience Corporation
TVTX
Travere Therapeutics, Inc.
STOK
Stoke Therapeutics, Inc.